Fred Hassan, Director of BridgeBio Pharma BBIO, has filed 1 purchase and 0 sales on the open market. The latest trade was on 06/22.

FH

FH

Fred Hassan

Director

Company

BridgeBio Pharma BBIO

First filing

23/03/13

Trades

40 trades

Buys / sales

1 / 0

12-month net buying

No record

Last trade

06/22

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
PrecigenPGEN	Open-market buy	23/08/14	23/08/16	570,345 sh	$1.75	$998,103.75	+184.8%